Nonpoint source pollution, characterized by its diffuse origins and transport mechanisms, remains a central barrier to global ...

The most recent short interest data has been released by the NASDAQ for the 08/15/2014 settlement date, which shows a 1,074,336 share decrease in total short interest for NPS Pharmaceuticals Inc ...

Shares of NPS Pharmaceuticals (NPSP) soared in afternoon trading Wednesday after the FDA said Natpara decreased the need for calcium and vitamin D supplements in clinical trials.

Keep a close eye on NPSP. Rumors surfaced that the company could be the target of a buyout. According to a report from The Times of London, Shire plc has lined up a $5 billion credit facility from ...

NPS Pharmaceuticals to Present Data from Natpara™ REPLACE Study and PARADOX Study at ENDO 2013, The Endocrine Society's 95 th Annual Meeting BEDMINSTER, N.J.--(BUSINESS WIRE)-- NPS ...